Table 2.
Changes in phenotype | Changes in function | ||
---|---|---|---|
Up-regulated expression | Down-regulated expression | ||
NK cell | ILT2, ILT3, ILT4, KIR2DL4, TNF-α, IFN-γ, MIP-1, MIP-3, IL-1β, IL-6, IL-8, IL-23 | CXCR3, CX3CR1, CCR2 | Inhibition of cytotoxic function, proliferation, and chemotaxis Induction of apoptosis Increased secretion of pro-angiogenic factors |
CD4+ T cell | ILT2, ILT3, ILT4, KIR2DL4, IL-3, IL-4, IL-10 | CD4, CCR2, CXCR3, CXCR5, TNF-α, IFN-γ | Inhibition of alloreactivity, proliferation, and chemotaxis Induction of anti-inflammatory response by shifting the Th1/Th2 balance Induction of regulatory/suppressive cells |
CD8+ T cell | ILT2, ILT3, ILT4, KIR2DL4 | CXCR3 | Inhibition of cytotoxic function, proliferation, and chemotaxis Induction of apoptosis Induction of regulatory cells |
DCs | ILT2, ILT3, ILT4, KIR2DL4, IL-1β, CD83a | HLA-DR, CD80, CD86, HLA-DM, GILT, CD74, LAMP3, Dynactin 2, Dectin-1, DCSTAMP | Inhibition of maturation Induction of tolerogenic state Induction of T cell tolerance |
Macrophage | CD163, IDO-1, IL-6, CXCL1, IL-12, TGF-β | CD86 | Inhibition of phagocytic function Induction of differentiation toward M2-like phenotype |
B cell | CXCR4, CXCR5 | Inhibition of Ig secretion, proliferation, and chemotaxis | |
Neutrophil | Reactive oxygen species | Inhibition of phagocytic function |